Related Articles
Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: A role for TGFβ1
Antitumor activity of chemoendocrine therapy in premenopausal and postmenopausal models with human breast cancer xenografts
Differential microRNA expression profiles in tamoxifen-resistant human breast cancer cell lines induced by two methods
Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231 cells
Combination treatment with proteasome inhibitors and antiestrogens has a synergistic effect mediated by p21WAF1 in estrogen receptor-positive breast cancer